Marshall Wace’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-294,527
Closed -$8.68M 3620
2025
Q4
$8.68M Buy
294,527
+103,422
+54% +$2.87M 0.01% 931
2025
Q3
$4.83M Sell
191,105
-37,784
-17% -$921K ﹤0.01% 1193
2025
Q2
$5.49M Sell
228,889
-100,633
-31% -$2.33M 0.01% 1097
2025
Q1
$7.55M Sell
329,522
-110,916
-25% -$2.68M 0.01% 881
2024
Q4
$11.2M Buy
440,438
+254,028
+136% +$6.44M 0.01% 760
2024
Q3
$4.65M Buy
186,410
+17,766
+11% +$526K 0.01% 1021
2024
Q2
$5M Sell
168,644
-179,940
-52% -$4.99M 0.01% 989
2024
Q1
$10.5M Buy
+348,584
New +$9.67M 0.02% 733
2023
Q2
Sell
-49,228
Closed -$1.8M 2912
2023
Q1
$1.8M Buy
+49,228
New +$1.55M ﹤0.01% 1508

Other funds holding RTO

Marshall Wace's RTO Position: Q1 2026 in Review

Marshall Wace sold out of Rentokil (RTO) in Q1 2026, closing a stake of 294,527 shares — an estimated $8.68M sold.

Marshall Wace first reported a position in RTO in Q1 2023 and held it in 9 quarters. The position peaked at $11.2M in Q4 2024. 284 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • Marshall Wace reported no remaining Rentokil position as of Q1 2026 after selling out during the quarter.
  • Marshall Wace sold 294,527 Rentokil shares in Q1 2026, an estimated $8.68M.
  • Marshall Wace first reported a position in Rentokil in Q1 2023 and held it in 9 quarters.
  • Marshall Wace's Rentokil position peaked at $11.2M in Q4 2024.
  • 284 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.